Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
- Featured Article
Regulatory changes, including the launch of ICH E6(R3) and Good Clinical Practice (GCP) updates, have highlighted...
Source: International Pharmaceutical Industry
- Featured Article
Sophie Henderson, Senior Strategic Consultant at CluePoints, said: “This year we have seen risk-based quality management...
Source: Discover Pharma
- Press Release
CluePoints Scoops Prestigious 2025 Scrip Award RBQM and AI leader wins the ‘Best Contract Research Organization...
- Press Release
King of Prussia, PA – November 5th, 2025: CluePoints, provider of leading statistical and AI-driven software...
- Featured Article
As clinical trials become more complex, leading sponsors are shifting the focus of their clinical research...
Source: The Association of Clinical Research Professionals
- Featured Article
Source: Applied Clinical Trials
- Press Release
The RBQM and AI leader wins the ‘Clinical Data Science Implementation Excellence Award’ at SCDM 2025...
- Press Release
KING OF PRUSSIA, Pa., Sept. 23, 2025 /PRNewswire/ — CluePoints, the premier sponsor of RBQMLive and...
- Featured Article
Ken McFarlane of CluePoints shares insight on better, smarter ways to detect risk, streamline data review,...
Source: Contract Pharma
- Featured Article
As a follow-up to Clinical Trials Day 2025, held on May 20 with the theme of...
Source: The Association of Clinical Research Professionals
- Featured Article
“Identifying … potential data manipulation and data integrity problems” are an International Council for Harmonization of...
Source: Applied Clinical Trials
- Featured Article
Artificial Intelligence (AI) continues to gain momentum in the pharmaceutical sector, but can it truly deliver...
Source: Health Tech World
- Press Release
King of Prussia, PA – January 19, 2021: CluePoints, the premier provider of Risk-Based Study Execution...
- Press Release
King of Prussia, PA – December 8th, 2020: CluePoints, the premier provider of Central Statistical Monitoring,...
- Press Release
LOUVAIN-LA-NEUVE, BELGIUM; KING OF PRUSSIA, PA; and LONDON, UK (September 1, 2020) – CluePoints S.A., a...
- Press Release
Addressing COVID-19 Specific Regulatory Guidance and Ensuring Early Risk Detection King of Prussia, PA: CluePoints, the...
- Press Release
On July 28, CluePoints is teaming up with DIA for a webinar to explore how the...
- Press Release
Personalizing the Power of Statistical Analysis and Data Visualization King of Prussia, PA: CluePoints, the premier...
- Press Release
RISK MANAGEMENT SOLUTION ADDRESSES FDA, EMA, PMDA & MHRA CORONAVIRUS ADVICE King of Prussia, PA: CluePoints,...
- Press Release
King of Prussia, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality...
- Press Release
Risk Planning Guidance Addresses FDA, EMA, PMDA and MHRA Coronavirus Advice King of Prussia, PA: CluePoints,...
- Press Release
We’re delighted to announce that the recording for our COVID-19 webinar has been posted! About the...
- Press Release
Remote monitoring is mitigating the impact of SARS-CoV-2 on clinical trials, marking an acceleration in the...
- Press Release
King of Prussia, PA: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality...
- Featured Article
By empowering researchers to detect data quality issues in real-time, Risk-Based Quality Management (RBQM) and Risk-Based...
Source: Journal for Clinical Studies
- Featured Article
Amid the ongoing Coronavirus pandemic, clinical trial sites are increasingly inaccessible for patients and site staff,...
Source: Tufts Center for the Study of Drug Development
- Featured Article
The use of direct source data capture in clinical research is on the rise, both during...
Source: Clinical Research News
- Featured Article
The clinical research industry has gone through an important transformation over the past 15 to 20...
Source: ACRP
- Featured Article
Poor quality data has the potential to destroy the validity of a clinical trial, wasting precious...
Source: Tufts Center for the Study of Drug Development
- Featured Article
Participant safety is the clinical trial sector’s top priority – and striving to achieve this laudable...
Source: Applied Clinical Trials
- Featured Article
The latest version of the Good Clinical Practice (GCP) quality standard insists that sponsors implement a...
Source: Global Forum
- Featured Article
A risk-based approach to clinical research may include a central statistical assessment of data quality.
...Source: Sage Journals
- Featured Article
Not only is there a significant good clinical practice (GCP) expectation, Risk-Based Monitoring (RBM) presents a...
Source: Contract Pharma
- Featured Article
Since finalizing its risk-based monitoring guidance in 2013, the FDA is providing additional information in a...
Source: Outsourcing Pharma
- Featured Article
Since the introduction of the ICH E6 (R2) addendum, the industry has seen a rise in...
Source: Pharma Focus Asia
- Featured Article
The ICH E6 R2 Addendum is starting to have a significant, positive impact on clinical trial...
Source: Contract Pharma
